Proton therapy developer Ion Beam Applications (IBA) posted revenue increases for its first half of 2017.
For the period (end-June 30), total revenues increased 4.5% to 152 million euros ($179.2 million U.S.), compared with 145 million euros ($171 million) for the same period in 2016. The company's sales of proton therapy and accelerators increased by 1.7% to 123 million euros ($145 million), while its dosimetry business segment increased by 18.7% to 28.4 million euros ($33.5 million).
